![]()
Seasoned attorney and cross-border business development advisor joins after demand arrived from five countries unprompted
PHOENIX, AZ AND NEWPORT BEACH, CA / ACCESS Newswire / October 13, 2026 / Enyrgy Inc. has appointed Natalia Lantonio to its Financial Advisory Council, where she will focus on domestic and international business development as the Company builds on demand from five countries which the Company did not originally target.
Natalia’s expertise is domestic buildout, international expansion, market opportunity and cross-border growth. Enyrgy has users in the United States, the United Kingdom, Canada, France and New Zealand, and each of those markets reached the company before the company reached it. Turning that into deliberate expansion, market by market and partner by partner, is where Natalia will provide depth and guidance.
Natalia has spent a decade engaged in cross-border business verticals including technology, entertainment and real estate. She has advised technology start-ups on international expansion and United States market entry, and built partnerships in the Middle East through Sustainable Success Management Consulting. At MagicQuest Entertainment, a Hollywood motion picture company, she oversaw international feature film development, negotiated agreements during the development of a $30 million picture, and cut administrative costs by 30 percent through vendor negotiation.
She is trained as an international lawyer and was previously in-house legal counsel at RESO Holding Company. Natalia is now based in Newport Beach, California.
“Five countries found us without asking,” said Scott Hansbury, co-founder and CEO of Enyrgy. “Having lived and done business across North America, the United Kingdom, France and Spain, I know the difference between interest in a market and conducting business in one. Natalia has spent her career closing that distance. We intend to build these markets strategically.”
About Enyrgy Inc.
Enyrgy Inc. is a private health technology company in Phoenix, Arizona. Its Enyrgy Vitamin D Primal Light Platform emits over 90 percent UVB and under 10 percent UVA, verified by an independent laboratory, the inverse of natural sunlight’s roughly 95 percent UVA. A session runs two to four minutes and supports vitamin D synthesis, nitric oxide release and serotonin production. The app calculates each user’s dose from their skin type and ends the session automatically.
Efficacy, safety and usability are the three tenets the platform is built on, in that order, and the company treats efficacy as something to keep testing rather than something already settled. Larger trials are in development.
The platform has completed more than 25,000 sessions with a clean safety record, across more than 600 users in five countries. Enyrgy has never run paid advertising. The return rate is under 1 percent, against an industry average of 5 to 10 percent, and the units are built in Phoenix. Dr. Derrick Holman, M.D., serves as the company’s medical director, and its Scientific Advisory Board includes Dr. Bruce Hollis, Dr. Samantha Kimball and Dr. William Grant.
Media contact: contact@enyrgy.com, (888) 316-1695, enyrgy.com
Enyrgy is a wellness device and is not a medical device. Enyrgy does not diagnose, treat, cure or prevent any disease. Statements regarding the Enyrgy device have not been evaluated by the Food and Drug Administration.
SOURCE: Enyrgy Inc
View the original press release on ACCESS Newswire
Media gallery